“[Tecfidera® (delayed-Release Dimethylfumarate) in the Treatment of Relapsing-Remitting Multiple Sclerosis]”. Farmeconomia. Health Economics and Therapeutic Pathways 18, no. 2S (December 1, 2017). Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1320.